Clinical Trial Update: ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations [Phase 4]

View source ↗

Summary

Phase 4 ASSURE trial evaluating risk reduction with a single-shock defibrillation threshold strategy versus ultra-low energy in patients with implantable cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tachyarrhythmia

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Tachyarrhythmia | Phase 4 | Status: COMPLETED